Effects and side effects do not always begin at the same time
Venlafaxine is an antidepressant prescribed for depression and several anxiety disorders, among other conditions. Its benefits are not immediate, while side effects can begin during the first days or weeks. That difference understandably raises questions.
The Dutch National Health Care Institute recorded 94,208 venlafaxine users in reimbursed care in 2025. This is a user count, not an assessment of why people take it, how long treatment lasts or what the outcome is.
Why effects and side effects can overlap
Apotheek.nl explains that benefits may take several weeks to become noticeable, while digestive problems, dry mouth, headache, sweating, dizziness, tiredness and sexual symptoms can begin earlier. People do not all experience the same symptoms, and not every symptom is necessarily caused by venlafaxine.
The updated Zorgfuik dossier translates the Dutch information into plain English. It separates symptoms that can be tracked, situations in which speaking with a doctor or pharmacist is sensible and warning signs that require urgent help. It also provides concrete questions to prepare a conversation about benefits and side effects.
Not addictive does not mean easy to stop
Venlafaxine does not usually cause the intoxication and compulsive seeking associated with classic addiction. The body can still adapt to the medicine. The official Dutch patient leaflet and the Dutch Pharmacotherapeutic Compass therefore warn about withdrawal symptoms when stopping abruptly or reducing too quickly.
The page deliberately provides no personal tapering schedule. The pace and support required depend on the person, duration of use, other medicines and medical situation. Do not change the dose yourself. Discuss stopping or reducing with the prescriber and pharmacist.
Experiences can reveal questions that were missed
Personal experiences do not prove that a symptom was caused by venlafaxine. They can show which questions are often not discussed, such as review dates, persistent side effects or support when stopping. Zorgfuik therefore invites people to share what happened. A short and anonymous account is welcome too.
Sources and review
- National Health Care Institute, Zorgcijfersdatabank: Dutch antidepressant and venlafaxine user figures up to 2025.
- Apotheek.nl: effects, possible side effects, interactions and stopping.
- Medicines Evaluation Board database: official Dutch patient leaflet for venlafaxine.
- Dutch Pharmacotherapeutic Compass: product information, warnings and withdrawal symptoms.
Last content review: 28 July 2026.
Do you recognise this?
Did you notice an improvement, experience side effects or become stuck during long-term use or stopping? Share what happened. A short and anonymous account is welcome.